status

(redirected from estrogen receptor status)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

Status

The standing, state, or condition of an individual; the rights, obligations, capacities, and incapacities that assign an individual to a given class.

For example, the term status is used in reference to the legal state of being an infant, a ward, or a prisoner, as well as in reference to a person's social standing in the community.

status

noun caliber, caste, circumstance, class, dignity, elevation, eminence, esteem, footing, grade, importance, notability, place, position, posture, prestige, prominence, quality, rank, rating, situation, state, station, superiority
Associated concepts: proof of status, status of purchaser, staaus of trustee
See also: aspect, caliber, case, character, class, condition, credit, degree, honor, phase, position, posture, precedence, prestige, quality, rating, recognition, reputation, situation, state, title

STATUS. The condition of persons. It also means estate, because it signifies the condition or circumstances in which the owner stands with regard to his property. 2 Bouv. Inst. n. 1689.

References in periodicals archive ?
Major Finding: Estrogen receptor status changed from positive in the primary to negative in the relapse in 26% of patients and from negative to positive in 7%.
Intranucleolar nucleolin distribution during cell cycleprogressionin human invasive ductal breast carcinomas in relation to estrogen receptor status.
1 Table 2: Age and Estrogen Receptor Status is Compared Age of Patients Oestrogen Oestrogen Receptor Receptor Positive Negative 30-35 yrs.
Radiation therapy reduced the risk of recurrence in patients who were younger than 40 years old, T2 stage, high nuclear grade, had negative estrogen receptor status and had presence of lymphovascular invasion from 40 percent to 12.
Estrogen receptor status by immunohistochemistry is superior to the ligand binding assay for predicting response to adjuvant endocrine therapy in breast cancer.
2]) greater than 25 faced a 42%-46% increased risk of developing distant metastasis, even after investigators adjusted for numerous other prognostic factors such as age, tumor size, histologic characteristics, estrogen receptor status, and lymph node involvement.
46-fold higher risk of dying, compared with women in the 45-49 age group, a finding that persisted after adjustment for estrogen receptor status (BM) 320[7233]:474-79, 2000).
US LABS, through its collaboration with Arcturus, has internally validated signatures for estrogen receptor status and recurrence in invasive breast cancers.

Full browser ?